Alerts will be sent to your verified email
Verify Email
EUROASIA
|
RRP Defense
|
Remus Pharmaceutical
|
State Trading Corp
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
2.37 % | 38.78 % | 0.5 % |
|
5yr average Equity Multiplier
|
2.69 | 2.69 | -0.53 |
|
5yr Average Asset Turnover Ratio
|
2.19 | 1.34 | 0.25 |
|
5yr Avg Net Profit Margin
|
2.25 % | 12.12 % | -4.53 % |
|
Price to Book
|
402.91 | 0.0 | 0.0 |
|
P/E
|
735.12 | 43.25 | 115.95 |
|
5yr Avg Cash Conversion Cycle
|
4.11 Days | 62.15 Days | 0.0 |
|
Inventory Days
|
0.06 Days | 29.3 Days | 0.04 Days |
|
Days Receivable
|
13.91 Days | 196.63 Days | 0.0 |
|
Days Payable
|
203.03 Days | 131.74 Days | 57.22 Days |
|
5yr Average Interest Coverage Ratio
|
-5.87 | 52.6 | -2.4 |
|
5yr Avg ROCE
|
7.13 % | 46.86 % | -0.04 % |
|
5yr Avg Operating Profit Margin
|
-7.41 % | 14.35 % | -8.07 % |
|
5 yr average Debt to Equity
|
0.73 | 0.17 | -0.43 |
|
5yr CAGR Net Profit
|
n/a | 83.69 % | n/a |
|
5yr Average Return on Assets
|
1.2 % | 16.02 % | -0.89 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
1.85 % | 70.85 % | 90.0 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
-14.33 % | 1.24 % | 0.0 |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
RRP Defense
|
Remus Pharmaceutical
|
State Trading Corp
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|